Dr. Tavis Campbell, PhD
Cumming School of Medicine, Department of Oncology
Libin Cardiovascular Institute
Arnie Charbonneau Cancer Institute
Office: (403) 210-8606
B.S. Psychology, Concordia University,
Doctor of Philosophy Clinical Psychology, McGill University,
Areas of Research
The purpose of this project is to design, develop, and test a brief web-based intervention to improve adherence to personal protective behaviours related to COVID-19 prevention among the Canadian general population, with a focus on physical distancing, face masks and vaccination, and to examine the differential effect of this approach among young adults (25 and younger) and males who are at higher risk for non-adherence to protective behaviours. Funding for this project was received by the Canadian Institute of Health Research (CIHR), COVID-19 Research Gaps and Priorities Grant.
The purpose of the Small Changes in PsA study is to develop and test a small-changes behavioral weight loss approach for patients with PsA and obesity. This two-part study consists of a (1) a qualitative investigation to explore barriers and facilitators to behavioural weight loss treatment among patients with PsA and obesity, and (2) a randomized controlled trial to test whether patients who participate in the behavioural weight loss program are more likely to lose weight compared with those who receive treatment as usual from their community rheumatology clinic. This study is being done in collaboration with co-investigators Dr. Michelle Teo and Dr. Lesley Lutes.
This RCT is evaluating the efficacy of intranasal oxytocin versus placebo in improving outcomes among women with chronic pelvic pain. The primary objective is to investigate oxytocin’s efficacy in reducing pain among women with chronic pelvic pain. Secondary objectives include investigating oxytocin’s efficacy in improving emotional function, physical function, and sleep among these women. This study is being done in collaboration with co-investigator Dr. Joshua Rash.
The purpose of the BE-WEL in CR-AF study is to develop and test a small-changes behavioral weight loss approach for patients with atrial fibrillation (AF) and obesity attending a cardiac rehabilitation program. This two-part study consists of a (1) a qualitative investigation to explore barriers and facilitators to behavioural weight loss treatment among patients with AF and obesity, and (2) a randomized controlled trial to test whether patients who receive the behavioural weight loss component during their cardiac rehabilitation program, are more likely to lose 10% of their body weight than those who do cardiac rehab alone. Recruitment for Part I is currently underway.
- Fellow, Canadian Psychological Association. 2020
- Fellow, Academy of Behavioral Medicine Research. 2016
- Established Researcher Award, Faculty of Arts, University of Calgary. 2016
- Factors affecting the reception of self-management health education: A cross-sectional survey assessing perspectives of lower-income seniors with cardiovascular conditions. Tran, S., Weaver, R. G., Manns, B. J., Saunders-Smith, T., Campbell, T. S., Ivers, N., Hemmelgarn, B., Tonelli, M., Pannu, R., & Campbell, D. Patient Preference and Adherence. (2022)
- Assessing physician’s motivational communication skills: A 5-step mixed-methods development study of the Motivational Communication Competency Assessment Test (MC-CAT). Gosselin Boucher, V., Bacon, S. L., Voisard, B., Dragomir, A. I., Gemme, C., Larue, F., Labbé, S., Szczepanik, G., Corace, K., Campbell, T. S., Vallis, M. T., Garber, G., Rouleau, C. R., Diodati, J. G, Rabi, D., Sultan, S., & Lavoie, K. JMIR Medical Education. S492. (2022)
- Characterizing and evaluating diurnal salivary uric acid across pregnancy among healthy women. Riis, J. L., Cook, S. H., Letourneau, N., Campbell, T. S., Granger, D. A., & Giesbrecht, G. F. Frontiers in Endocrinology, Clinical Diabetes. (2022)
- Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: Protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial. Rash, J. A., Campbell, T. S., Cooper, L. K., Flusk, D., MacInnes, A., Nasr-Esfahani, M., Mekhael, A. A., Poulin, P. A., Robert, M., & Yi, Y. BMJ Open. (2021)
- Identification of patients with COPD in a cardiac rehabilitation setting. Ozemek, C., Arena, R., Rouleau, C. R., Campbell, T. S., Hauer, T., Wilton, S. B., Stone, J., Laddu, D., Williamson, T. M., Liu, H., Austford, L. D., Roman, M. A., & Aggarwal, S. Journal of Cardiopulmonary Rehabilitation and Prevention. 172-175. (2021)
- Health behavior change programs in primary care and community practices for cardiovascular disease prevention and Risk Factor Management among midlife and older adults: A scientific statement from the American Heart Association. Laddu, D., Ma, J., Kaar, J., Ozemek, C., Durant, R. W., Campbell, T. S., Welsh, J., & Turrise, S. Circulation. e533–e549. (2021)
- Cancer and cardiovascular disease: The impact of cardiac rehabilitation and cardiorespiratory fitness on survival. Williamson, T., Moran, C., Chirico, D., Arena, R., Ozemek, C., Aggarwal, S., Campbell, T. S., & Laddu, D. International Journal of Cardiology. 139-145. (2021)
In the News
- Check out an interview with Dr. Campbell about the new iPROTECT study. University of Calgary News. (2021)
Are you the profile owner?
Login to edit.